MIT's Technology Review speaks with Knome's Jorge Conde about his company's $100,000 service, down from $350,000 when it launched in 2007. Conde doesn't say how many people Knome has sequenced but does note that 80 percent have been men in their mid-50s and that many customers are from outside the US. Sequencing is done at the Beijing Genomics Institute, then analyzed at Knome, and given to the customer on a USB drive during a day-long meeting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.